/ Not yet recruitingNot Applicable A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic Lymphocytic Leukemia (CLL) - --
100 Clinical Results associated with Cephalon (UK) Ltd.
0 Patents (Medical) associated with Cephalon (UK) Ltd.
100 Deals associated with Cephalon (UK) Ltd.
100 Translational Medicine associated with Cephalon (UK) Ltd.